Tierra Biosciences is a synthetic biology company that offers an AI-driven platform with a vast range of custom proteins for research.
Tierra Biosciences has raised $11.4M in total funding. The most recent round was Series A. The last funding was announced in March 2024.
Tierra Biosciences's investors include National Science Foundation, Material Impact, Creative Ventures, Fifty Years, KdT Ventures.
Tierra Biosciences is headquartered in San Leandro, United States.
Tierra Biosciences is a synthetic biology company that offers an AI-driven platform with a vast range of custom proteins for research.
Tierra Biosciences is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Tierra Biosciences — Funding & Investors." VCBacked, March 12, 2024, https://www.vcbacked.co/company/tierra-biosciences. Accessed September 14, 2026.
VCBacked. (2024). Tierra Biosciences — Funding & Investors. Retrieved September 14, 2026, from https://www.vcbacked.co/company/tierra-biosciences
{{cite web |title=Tierra Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/tierra-biosciences |website=VCBacked |access-date=September 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated